BDBM221499 6-{[(1r)-1- cyclobutylethyl]amino}- 8-[(1-pyridin-2- ylethyl)amino]-7-[4- (trifluoromethyl)benzyl]- 7h-purine-2- carboxylic acid::US9540377, 9.31
SMILES: C[C@@H](Nc1nc(nc2nc(NC(C)c3ccccn3)n(Cc3ccc(cc3)C(F)(F)F)c12)C(O)=O)C1CCC1
InChI Key: InChIKey=HBWSXGBBYWULPR-AAFJCEBUSA-N
Data: 1 IC50
Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
p53-binding protein Mdm2 (Homo sapiens (Human)) | BDBM221499 (6-{[(1r)-1- cyclobutylethyl]amino}- 8-[(1-pyridin-...) | PDB GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.526 | n/a | n/a | n/a | n/a | n/a | 25 |
Merck Sharp & Dohme Corp. US Patent | Assay Description An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with re... | US Patent US9540377 (2017) BindingDB Entry DOI: 10.7270/Q2RF5X1F | |||||||||||
More data for this Ligand-Target Pair |